Section Arrow
Quote
SPTX.NASDAQ
- Seaport Therapeutics, Inc.
Quotes are at least 15-min delayed:2026/06/20 17:09 EDT
Regular Hours
Last
 18.17
+1.07 (+6.26%)
Day High 
18.28 
Prev. Close
17.1 
1-M High
19.3 
Volume 
1.33M 
Bid
7.19
Ask
18.29
Day Low
16.91 
Open
17.44 
1-M Low
15 
Market Cap 
915.37M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 17.35 
20-SMA 17.43 
50-SMA -- 
52-W High 23 
52-W Low 14.85 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.64/--
Enterprise Value
918.82M
Balance Sheet
Book Value Per Share
-2.16
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc.0.01+0.0056+127.27%-- 
CDTCDT Equity Inc.1.02+0.327+47.19%-- 
AZTRAzitra0.1717-0.0313-15.42%-- 
CRVOCervoMed4.24+0.43+11.29%-- 
OCGNOcugen1.24+0.01+0.81%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.